Download the gene annotation in CSV format
KEGG pathway | KEGG ID | KEGG IC |
---|---|---|
Signaling pathways regulating pluripotency of stem cells | hsa04550 | 5.6 |
Pathogenic Escherichia coli infection | hsa05130 | 6.99 |
Basal cell carcinoma | hsa05217 | 6.79 |
Bacterial invasion of epithelial cells | hsa05100 | 6.34 |
Proteoglycans in cancer | hsa05205 | 5.02 |
Endometrial cancer | hsa05213 | 6.81 |
Colorectal cancer | hsa05210 | 6.52 |
Thyroid cancer | hsa05216 | 7.48 |
Pathways in cancer | hsa05200 | 3.98 |
Prostate cancer | hsa05215 | 6.11 |
Tight junction | hsa04530 | 5.53 |
Rap1 signaling pathway | hsa04015 | 4.97 |
Leukocyte transendothelial migration | hsa04670 | 5.74 |
Melanogenesis | hsa04916 | 5.97 |
Adherens junction | hsa04520 | 6.26 |
Focal adhesion | hsa04510 | 4.92 |
Hippo signaling pathway | hsa04390 | 5.37 |
HTLV-I infection | hsa05166 | 4.59 |
Thyroid hormone signaling pathway | hsa04919 | 5.82 |
Wnt signaling pathway | hsa04310 | 5.49 |
Arrhythmogenic right ventricular cardiomyopathy (ARVC) | hsa05412 | 6.32 |
REACTOME pathway | REACTOME ID | REACTOME IC |
---|---|---|
Immune System | R-HSA-168256 | 2.37 |
Signaling by Rho GTPases | R-HSA-194315 | 4.43 |
Apoptotic execution phase | R-HSA-75153 | 7.28 |
Programmed Cell Death | R-HSA-5357801 | 5.65 |
Peptide hormone metabolism | R-HSA-2980736 | 6.61 |
deactivation of the beta-catenin transactivating complex | R-HSA-3769402 | 7.59 |
CDO in myogenesis | R-HSA-375170 | 8.12 |
disassembly of the destruction complex and recruitment of AXIN to the membrane | R-HSA-4641262 | 8.03 |
Adherens junctions interactions | R-HSA-418990 | 7.98 |
Synthesis, secretion, and inactivation of Glucagon-like Peptide-1 (GLP-1) | R-HSA-381771 | 8.66 |
binding of TCF/LEF:CTNNB1 to target gene promoters | R-HSA-4411364 | 10.18 |
Developmental Biology | R-HSA-1266738 | 3.48 |
repression of WNT target genes | R-HSA-4641265 | 9.28 |
T41 mutants of beta-catenin aren't phosphorylated | R-HSA-5358752 | 9.08 |
S45 mutants of beta-catenin aren't phosphorylated | R-HSA-5358751 | 9.08 |
Apoptotic cleavage of cellular proteins | R-HSA-111465 | 7.73 |
Beta-catenin phosphorylation cascade | R-HSA-196299 | 8.89 |
Cell-cell junction organization | R-HSA-421270 | 7.03 |
Ca2+ pathway | R-HSA-4086398 | 7.1 |
Disease | R-HSA-1643685 | 3.33 |
Myogenesis | R-HSA-525793 | 8.12 |
RHO GTPases activate IQGAPs | R-HSA-5626467 | 8.34 |
VEGFA-VEGFR2 Pathway | R-HSA-4420097 | 4.7 |
Diseases of signal transduction | R-HSA-5663202 | 4.89 |
beta-catenin independent WNT signaling | R-HSA-3858494 | 5.83 |
Innate Immune System | R-HSA-168249 | 3.17 |
Cell junction organization | R-HSA-446728 | 6.51 |
Metabolism of proteins | R-HSA-392499 | 3.41 |
LRR FLII-interacting protein 1 (LRRFIP1) activates type I IFN production | R-HSA-3134973 | 10.66 |
Cytosolic sensors of pathogen-associated DNA | R-HSA-1834949 | 6.94 |
Incretin synthesis, secretion, and inactivation | R-HSA-400508 | 8.46 |
VEGFR2 mediated vascular permeability | R-HSA-5218920 | 8.28 |
Cell-Cell communication | R-HSA-1500931 | 5.87 |
RHO GTPase Effectors | R-HSA-195258 | 4.94 |
Signaling by Wnt | R-HSA-195721 | 4.79 |
formation of the beta-catenin:TCF transactivating complex | R-HSA-201722 | 7.18 |
misspliced GSK3beta mutants stabilize beta-catenin | R-HSA-5339716 | 9.08 |
S33 mutants of beta-catenin aren't phosphorylated | R-HSA-5358747 | 9.08 |
S37 mutants of beta-catenin aren't phosphorylated | R-HSA-5358749 | 9.08 |
Degradation of beta-catenin by the destruction complex | R-HSA-195253 | 6.64 |
Signaling by WNT in cancer | R-HSA-4791275 | 7.89 |
Signaling by VEGF | R-HSA-194138 | 4.66 |
Apoptosis | R-HSA-109581 | 5.68 |
phosphorylation site mutants of CTNNB1 are not targeted to the proteasome by the destruction complex | R-HSA-4839743 | 9.08 |
TCF dependent signaling in response to WNT | R-HSA-201681 | 5.36 |
Apoptotic cleavage of cell adhesion proteins | R-HSA-351906 | 9.52 |
Signal Transduction | R-HSA-162582 | 1.78 |
GO term | GO ID | GO IC |
---|---|---|
protein C-terminus binding | GO:0008022 | 4.5 |
signal transducer activity | GO:0004871 | 2.28 |
activating transcription factor binding | GO:0033613 | 5.68 |
androgen receptor binding | GO:0050681 | 6.07 |
enzyme binding | GO:0019899 | 2.27 |
euchromatin binding | GO:1990188 | 9.05 |
macromolecular complex binding | GO:0044877 | 2.61 |
binding | GO:0005488 | 0.18 |
nucleic acid binding | GO:0003676 | 1.44 |
DNA binding | GO:0003677 | 1.92 |
ion channel binding | GO:0044325 | 5.02 |
heterocyclic compound binding | GO:1901363 | 1.06 |
repressing transcription factor binding | GO:0070491 | 5.71 |
transcription coactivator activity | GO:0003713 | 4.04 |
transcription cofactor activity | GO:0003712 | 3.44 |
SMAD binding | GO:0046332 | 5.45 |
transcription factor activity, transcription factor binding | GO:0000989 | 3.36 |
I-SMAD binding | GO:0070411 | 7.34 |
protein complex binding | GO:0032403 | 3.09 |
double-stranded DNA binding | GO:0003690 | 3.09 |
steroid hormone receptor binding | GO:0035258 | 5.32 |
estrogen receptor binding | GO:0030331 | 6.05 |
transcription regulatory region DNA binding | GO:0044212 | 3.03 |
regulatory region nucleic acid binding | GO:0001067 | 3.03 |
transcription factor binding | GO:0008134 | 3.46 |
transcription factor activity, protein binding | GO:0000988 | 3.35 |
nuclear hormone receptor binding | GO:0035257 | 4.7 |
ionotropic glutamate receptor binding | GO:0035255 | 6.56 |
glutamate receptor binding | GO:0035254 | 6.13 |
protein kinase binding | GO:0019901 | 3.44 |
kinase binding | GO:0019900 | 3.32 |
protein phosphatase binding | GO:0019903 | 4.93 |
phosphatase binding | GO:0019902 | 4.63 |
RNA polymerase II activating transcription factor binding | GO:0001102 | 6.13 |
hormone receptor binding | GO:0051427 | 4.57 |
cell adhesion molecule binding | GO:0050839 | 4.5 |
RNA polymerase II transcription factor binding | GO:0001085 | 5.08 |
nitric-oxide synthase binding | GO:0050998 | 6.91 |
transcription factor activity, sequence-specific DNA binding | GO:0003700 | 2.65 |
organic cyclic compound binding | GO:0097159 | 1.05 |
alpha-catenin binding | GO:0045294 | 7.44 |
cadherin binding | GO:0045296 | 6.41 |
protein binding | GO:0005515 | 0.46 |
regulatory region DNA binding | GO:0000975 | 3.03 |
receptor binding | GO:0005102 | 2.43 |
chromatin binding | GO:0003682 | 3.64 |
nucleic acid binding transcription factor activity | GO:0001071 | 2.65 |